Stocks
Spyre Therapeutics, Inc.SYRE
NASDAQHealthcareBiotechnology$90.33
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing precision therapies for patients with immune-mediated diseases, with a primary focus on inflammatory bowel disease. The company is advancing a pipeline of monoclonal antibodies and other biologics designed to target validated pathways with improved efficacy and convenience. Investors track Spyre for its late-stage programs and potential to address significant unmet needs in a large market.
52W Range: $21.14-$110.17
Congressional Interest in Spyre Therapeutics, Inc. (SYRE)
No congressional trades have been disclosed for Spyre Therapeutics, Inc. (SYRE) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading SYRE?
No congressional trades found for this stock.